DOCKING STUDIES FOR VARIOUS ANTIBACTERIAL BENZILATE DERIVATIVES by R, SUDHA et al.
Vol 10, Issue 4, 2017
Online - 2455-3891 
Print - 0974-2441
DOCKING STUDIES FOR VARIOUS ANTIBACTERIAL BENZILATE DERIVATIVES
SUDHA R1*, BRINDHA DEVI P2, CHARLES C KANAKAM3, NITHYA G1
1Department of Chemistry, School of Basic Sciences, Vels University, Chennai, Tamil Nadu, India. 2Department of Bioengineering, School 
of Engineering, Vels University, Chennai, Tamil Nadu, India. 3Depatment of Chemistry, Formerly Presidency College, University of Madras, 
Tamil Nadu, India. Email: rajendran.sudha7@gmail.com
Received: 21 December 2016, Revised and Accepted: 12 January 2017
ABSTRACT
Objectives: In this study, we have focused on discovering the leads for the enzyme targets of infectious disease tuberculosis. We employed computer-
aided drug design docking tool, to discover new leads for Mycobacterium tuberculosis (MTB).
Methods: Five compounds were synthesized and they are made to dock into the active site of the enzyme; retrieved from protein data bank.
Results: The docking studies and structure–activity relationship reveals that the compound 2’-chloro-4-methoxy-3nitro benzilic acid after three 
different docking strategies reveals that the score was found to be higher compared with others(−5.568 kcal/mol).
Conclusion: On the closer analysis of this molecule, the molecule showed stacking interaction and the compound has also found to be surrounded by 
non-polar amino acids, which makes this molecule potent toward antibacterial drug discovery.
Keywords: Antibacterials, Docking, Absorption, Distribution, Metabolism and excretion study, Resistance.
INTRODUCTION
As there is an increased number of drug-resistant bacterial cases 
worldwide, there is an urgent need for novel therapeutic interventions 
including innovative antibacterial and antimycobacterial drugs [1,2] 
with no cross-resistance to available drugs in the market. The most 
pathogenic bacteria Mycobacterium tuberculosis (MTB), the causative 
agent for tuberculosis in humans leads to a bacterial killer worldwide [3]. 
The bacteria have led to the emergence of multi-drug resistant and 
extensively drug resistant strains of bacteria. The treatment is based 
on the combination of two or more antibiotics, and the side effects are 
many. To limit the medications and side effects the preliminary studies 
have been done for the small molecule inhibitors which have been 
shown good antibacterial activity toward many pathogenic bacteria.
Recently, benzilic acid derivatives were synthesized as potent 
antibacterial agents with good activity range. They inhibit the 
pathogenic bacteria’s which includes Staphylococcus aureus, Klebsiella 
pneumoniae, Escherichia coli, and Staphylococcus epidermitis. Virtual 
screening, a computational method where the compounds could be 
assessed for their potential to bind specific sites on target molecules 
such as proteins, was employed in the study [4]. Furthermore, the 
pharmacokinetic properties were also predicted for future perspective 
of the small molecule compounds.
METHODS
Computational details
The computational details for this study were conducted in an Intel 
Core I5 capacity processor with memory of 4GB random access 
memory running with the windows 7 operating system. The virtual 
screening options for high throughput virtual screening (HTVS), 
standard precision (SP) and glide extra precision (XP) docking were all 
checked to be executed. The module glide XP of Schrodinger 9.3 (glide, 
version 5.7, Schrodinger, LLC, and New York, 2015) was utilized to 
perform docking studies. Suitable bonding and the charges were added 
to the hetero atoms and the corresponding hydrogen atoms were added 
to all the atoms [5].
Protein preparation
The protein file was prepared on protein preparation wizard and the 
energy minimization was performed. About 500 cycles of steepest 
descent and 5000 cycles of conjugate gradient methods with optimized 
potential for liquid simulations (OPLS) 2005 force field using 
Schrodinger suite version 9.3 were employed. Grid-A rectangular box 
surrounding the active site of the protein was located using receptor 
grid generation panel. The “Write XP descriptor information” option 
was selected and “compute root-mean-square deviation (RMSD)” 
option was enabled and rest of the parameters was kept as default. The 
XP glide scoring function was used to order the best-ranked compounds 
and the important interactions like π-cation and π-π stacking were 
analyzed using XP visualizer in glide module. The input RMSD of the 
crystal ligand was also ascertained [6].
Preparation of ligands
The synthesized molecules were processed through the Lipinski filters 
to enable the drug property. Ligand preparation was performed for the 
synthesized molecules using LigPrep module available in the software 
(LigPrep v2.2, Schrodinger LLC, NY) and Epik (Epik v1.6, Schrodinger, 
LLC, NY) to expand protonation and tautomeric states at 7.0±2.0 pH 
units. Conformational sampling was also performed for all database 
molecules using the Confgen search algorithm. Confgen with OPLS 
2005 force field was applied for the generation of conformers with 
duplicate poses eliminate if the RMSD was <2.0 Å. A distance-dependent 
dielectric constant of four and maximum relative energy difference of 
10 kcal/mol were applied [6].
Molecular docking
Docking studies for the synthesized compounds were performed 
using glide module of Schrodinger, LLC, 2015. Primarily, using glide 
module [7,8] (grid based ligand docking with energetics), we examined 
for important interactions based on the reference ligand and the protein 
of interest in the flexible mode docking. The glide module with three 
modes of docking, HTVS, SP, and XP mode was employed sequentially. 
The XP mode was used for exhaustive sampling and advanced scoring, 
resulting in even higher enrichment.
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Finally, the shortlisted hit molecules were selected based on the visual 
inspection of amino acid interaction, docking score, and the active site 
cavity [9].
ADME prediction
All the synthesized compounds for our study were selected, and the 
molecules were subjected to ADME predicted analysis using QikProp 
module of Schrodinger. The important properties such as octanol-
water coefficient (logP), human oral absorption, Lipinski’s rule of five, 
blood-brain barrier (BBB) coefficient, HERG property, and CaCO-2 
permeability property were predicted for the synthesized compounds, 
and also the predicted results were checked for any violations to 
determine the nature of the compounds.
RESULTS AND DISCUSSIONS
Synthesized compounds have taken for docking studies to establish 
the structure–activity relationship using crystal structure of MTB 
co-crystallized with inhibitor thiazole benzamide (protein data 
bank ID:4WYC). Analysis of crystal structure of 4WYC revealed with 
hydrogen bonding interactions with nonpolar interaction like Trp398. 
The inhibitor is well associated with hydrophobic amino acids met61, 
Trp398, Trp64, Tyr407, and phe402 [10]. To validate the active site 
pocket the reference ligand was redocked and the docking score 
was found to be −6.032 kcal/mol. Redocking results showed that the 
compound exhibited similar interactions as that of crystal structure and 
showed an RMSD of 1.02 Å. Further, the compounds synthesized were 
screened based on three different docking strategies [11]. The ligand 
interaction with protein was depicted in Fig. 1. The docking score and 
the ligand interactions for the compounds were tabulated in Table 1.
The compound 2’-chloro-4-methoxy-3-nitro benzilic acid was found 
to inhibit the pathogenic bacteria’s S. aureus, K. pneumoniae and E. coli 
at a distance of 10 mm using disc diffusion method, when compared 
to other compounds. The compound after three different docking 
strategies reveals that the score was found to be −5.568 kcal/mol. 
On the closer analysis of this molecule, the molecule showed similar 
stacking interaction like the reference molecule; the compound has 
also found to be surrounded by nonpolar amino acids, which makes 
this molecule potent toward antibacterial drug discovery. The binding 
analysis and ligand interaction diagram for the compound 2’-chloro-4-
methoxy-3-nitrobenzilic acid was depicted in Fig. 2.
Based on our docking studies, it has confirmed that the structure 
changes in the compounds series were found to be well correlated with 
in vitro antibacterial results. The compound 4, 4’-dibromo benzilic acid 
possessed high docking score of −5.228 kcal/mol with the stacking 
interaction with amino acid Trp64. The activity of this compound also 
found to be well correlated with the reference ligand. The close analysis 
of this compound revealed that the compound is well packed with 
nonpolar interactions which make this compound more active against 
the pathogenic bacteria. The binding analysis and ligand interaction 
diagram for the most active compound 4, 4’-dibromo benzylic acid are 
shown in Fig. 3. The docking score and its ligand interaction for the 
synthesized compounds are tabulated in Table 1.
The compound 2, 2’-dichloro benzilic acid was found to inhibit the 
bacteria at a distance of 8 mm. This is quite lesser than the other 
molecules. This makes this molecule more effective binding, and the 
docking score was found to be −5.121 kcal/mol. The binding analysis 
of this compound reveals that the compound well fitted into the active 
site pocket and the group phenyl chloride was found to interact with 
nonpolar amino acids Tyr25 and Trp64 which reveals that there are 
two stacking interactions making this compound more stable for 
further processing as better drug compound [12]. The binding analysis 
and ligand interaction for the compound 2, 2’-dichloro benzilic acid was 
depicted in Fig. 4.
The compound benzilic acid was found to inhibit the bacteria K. 
pneumoniae at a distance of 12 mm. This compound after in silico 
screening analysis was found to possess good docking score 
−5.069 kcal/mol. On the closer analysis of this compound reveals that 
the molecule has well fitted into the active site pocket of the protein; 
also their ligand interaction shows that the molecule was surrounded 
by nonpolar amino acid and it is found to be interact with an amino acid 
Trp64 which is an important interaction of original ligand. The binding 
Fig. 1: Reference ligand interaction with protein
Fig. 2: Binding analysis and ligand interaction diagram for 
2’-chloro-4-methoxy-3-nitro benzilic acid
Fig. 3: Binding analysis and ligand interaction diagram for the 
most active compound 4, 4’-dibromo benzilic acid
Table 1: Docking score and ligand interaction results for the 
synthesized compounds








2 4, 4’-dibromo benzilic acid −5.225 Tyr157
3 2, 2’-dichlorobenzilic acid −5.121 Trp64, Trp25
4 Benzilic acid −5.069 Trp64
5 Methyl benzilate −3.140 Trp64
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analysis and ligand interaction diagram for the compound methyl 
benzilate were depicted in Fig. 5.
The compound methyl benzilate does not show any antibacterial 
activity with any of the pathogenic bacteria’s. After molecular docking 
studies, the compound possesses less docking score −3.140 kcal/mol. 
The closer analysis of this reveals that the compound does not well 
fit into the active site of the enzyme. Furthermore, the benzyl moiety 
has facing outward which might have makes this compound less active 
when compared with other compounds virtually and biologically. The 
binding and ligand interaction for the compound methyl benzilate was 
shown in the Fig. 6.
ADME prediction
To further account for the potential of the compounds to act as 
efficient drug candidates, their absorption, distribution, metabolism, 
and excretion (ADME) properties were also calculated in silico using 
Qikprop. The obtained values for molecular logP, HERG property, 
CaCO accessibility, BBB, and human oral absorption; it is also used 
to assess violation of Lipinski’s rule of five if any. All the compounds 
were shown to correlate well with the human oral absorption. BBB 
separates the human brain from the direct contact of circulatory 
system, thus protecting the brain for unwanted solute particles. Both 
the predicted compounds were shown to be BBB negative ensuring 
their administration safe for the brain. The ADME predictions for the 
synthesized compounds were tabulated in Table 2.
CONCLUSIONS
We utilized the medicinal chemistry tools of structure-based drug 
design strategy. Docking studies were performed to identify new 
scaffold molecules. This strategy revealed hitherto unknown binding 
pockets and inhibitor binding modes distinct from the earlier reported 
inhibitors and will be exploited successfully in further antimycobacterial 
drug development process. The most active compound 2’-chloro-4-
methoxy-3-nitro benzilic acid was found to be most active in both 
in silico and in vitro antibacterial analysis. Further, these compounds 
will be carried out for their antimycobacterial property as these are 
small molecule leads could easily cross the cell barrier systems in 
mycobacteria.
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